Japanese Journal of Infectious Diseases

Papers
(The H4-Index of Japanese Journal of Infectious Diseases is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan337
Epidemiology of COVID-19 Outbreak in Japan, from January–March 202075
Cluster-Based Approach to Coronavirus Disease 2019 (COVID-19) Response in Japan, from February to April 202054
Increased Secondary Infection in COVID-19 Patients Treated with Steroids in New York City39
Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-1932
Japan Nosocomial Infections Surveillance (JANIS): Current Status, International Collaboration, and Future Directions for a Comprehensive Antimicrobial Resistance Surveillance System32
Assessment of Real-Time RT-PCR Kits for SARS-CoV-2 Detection32
SARS-CoV-2 in Italy: Population Density Correlates with Morbidity and Mortality28
Ultra-Rapid Real-Time RT-PCR Method for Detecting Middle East Respiratory Syndrome Coronavirus Using a Mobile PCR Device, PCR110026
The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak23
Inactivation of SARS-CoV-2 by Catechins from Green Tea22
Prediction of the Severity of the Coronavirus Disease and Its Adverse Clinical Outcomes21
Genome Recombination between the Delta and Alpha Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)20
Seasonality of Human Coronavirus OC43, NL63, HKU1, and 229E Infection in Yamagata, Japan, 2010–201918
Characterization of Colibactin-Producing <i>Escherichia coli</i> Isolated from Japanese Patients with Colorectal Cancer17
Predictors of Coronavirus Disease 2019 Severity: A Retrospective Study of 64 Cases17
Comparison of RT-PCR, RT-LAMP, and Antigen Quantification Assays for the Detection of SARS-CoV-217
0.021349906921387